Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. (ATR) is a global leader in providing a broad range of innovative dispensing systems for various markets, including beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage. Headquartered in Crystal Lake, Illinois, AptarGroup leverages its extensive manufacturing facilities across North America, Europe, Asia, and South America to serve customers worldwide.
Aptar's product portfolio includes aerosol valves, pumps, closures, and elastomer packaging components. The company operates through three primary business segments: Pharma, Beauty, and Closures. The Pharma division, which is the most significant contributor, is responsible for over two-thirds of the group's profits. The Beauty and Closures segments also play crucial roles in the company’s overall market strategy and revenue generation.
With the majority of its annual net sales stemming from Europe (50%) and the United States (33%), AptarGroup has been focusing on expanding its market presence in Asia (10%) and Latin America (7%). The company continually invests in research and development to maintain its competitive edge and deliver cutting-edge solutions to its clients.
Recent achievements for AptarGroup include strategic partnerships and product innovations that align with their commitment to sustainability and consumer satisfaction. The company continues to develop new dispensing technologies that are both eco-friendly and efficient, addressing the growing demand for sustainable packaging solutions.
For more detailed information about their products and services, visit their official website at www.aptar.com. Stay updated with AptarGroup’s latest developments and financial performance by following their news releases.
AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter results with reported sales growing 12% to $749 million. Core sales increased 5%, driven by demand in Pharma and Food & Beverage segments. Earnings per share rose 8% to $0.79. For the year, reported sales grew 2% to $2.93 billion, but earnings per share fell 12% to $3.21 due to pandemic impacts. The company achieved record cash flow from operations of $570 million and declared a quarterly dividend of $0.36 per share, highlighting its commitment to shareholders.
AptarGroup (NYSE: ATR) announces a partnership with CARE® to support global health initiatives, including the Fast + Fair COVID-19 Vaccine Response Campaign. This initiative aims to ensure equitable vaccine access for over 100 million people, focusing on women, impoverished communities, and healthcare workers across 10 countries. Aptar’s sponsorship emphasizes its commitment to diversity, inclusion, and women's empowerment, while aligning with its business model of producing vaccine delivery components. The collaboration promises to enhance CARE's efforts in advocating for equitable health policies worldwide.
AptarGroup, Inc. (NYSE: ATR) has announced that its Activ-Film™ technology will protect a new SARS Rapid Antigen test for COVID-19, recently granted Emergency Use Authorization (EUA) by the FDA. This QuickVue® SARS Antigen test, developed by Quidel® Corporation, delivers results in just 10 minutes, enhancing access to affordable COVID-19 testing, especially in schools and rural areas. Activ-Film™ integrates material science to ensure test accuracy by protecting against moisture and environmental factors. Aptar is dedicated to providing critical healthcare solutions during the pandemic.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, payable on February 17, 2021, to stockholders of record as of January 27, 2021. The company will also hold a conference call on February 19, 2021, at 8:00 a.m. Central Time to discuss its fourth quarter and year-end results for 2020. Additionally, the 2021 Annual Meeting of Stockholders will be held virtually on May 5, 2021, at 9:00 a.m. Central Time, with a record date for voting set for March 12, 2021.
AptarGroup, Inc. (NYSE: ATR) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, with a virtual presentation at 2:50 p.m. (EST) by key executives including President and CEO Stephan Tanda. A live webcast will be available in the Investors section of the Aptar website and a replay will be accessible for 90 days post-event. Aptar is a global leader in drug delivery and packaging solutions, headquartered in Crystal Lake, Illinois, employing 14,000 people across 19 countries.
AptarGroup, Inc. (NYSE: ATR) has announced the schedule for its quarterly conference calls for 2021. Key dates include:
- 4th Quarter and Annual Results: February 18, 2021 (Call on February 19, 2021, at 8:00 a.m. CT)
- 1st Quarter 2021 Results: April 29, 2021 (Call on April 30, 2021, at 8:00 a.m. CT)
- 2nd Quarter 2021 Results: July 29, 2021 (Call on July 30, 2021, at 8:00 a.m. CT)
- 3rd Quarter 2021 Results: October 28, 2021 (Call on October 29, 2021, at 8:00 a.m. CT)
Press releases will be issued after the close of trading on NYSE.
FAQ
What is the current stock price of Aptargroup (ATR)?
What is the market cap of Aptargroup (ATR)?
What products does AptarGroup manufacture?
Where is AptarGroup headquartered?
In which markets does AptarGroup operate?
What are the main business segments of AptarGroup?
Where does AptarGroup generate most of its sales?
What percentage of AptarGroup's profits come from the Pharma division?
Is AptarGroup expanding in any specific regions?
How does AptarGroup contribute to sustainability?
How can I stay updated with AptarGroup's latest news?
